Prostagene
Homepage http://prostagene.com
LinkedIn Profile https://linkedin.com/company/pr***age***
HQ Location
United States , Pennsylvania, Wynnewood100 Lancaster Avenue Room 133 Wynnewood, PA 19096 United States
ProstaGene is a biotechnology start up company that is developing technology based on patents of the Founder, Dr. Richard G. Pestell. ProstaGene LLC integrates proprietary molecular diagnostics with novel therapeutic screening and commercial experience in order to develop novel treatments for cancer.
The company has developed a diagnostic test that distinguishes benign from malignant prostate cancer with a predictive value of >98% in two retrospective clinical studies. The company has developed a prognostic test that defines a group of patients with poor outcome based on a signature of gene expression in the patients prostate tumor. The company has developed a novel platform for preclinical testing of therapies for metastatic prostate cancer in immune competent mice. The company has identified a therapeutic for metastatic prostate cancer that has shown to be highly effective in preclinical testing.
Biotechnology and Molecular Biology Research
Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.
Career Opportunities at Prostagene
Stay updated on the latest job openings by checking back regularly or by visiting the company's official career page.
No job listings currently found.
Details of Prostagene
Related Companies and Competitors
Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.
